Trial intelligence / Profile preview

Sirolimus Conversion in Pediatric Kidney Transplant

NCT02117596Completed

Sponsor
Pediatric Nephrology of Alabama
Start
Nov 2007
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of sirolimus in kidney transplant rejection, sponsored by Pediatric Nephrology of Alabama. Primary endpoint: Allograft function as determined by Schwartz GFR. Started Nov 2007; status: completed.

02

Drugs

sirolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT02117596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02117596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call